Hong Kong [email protected]
HealthLink

Expert Medical Knowledge
Sharing trusted health information

Prevention And Treatment Of Prostate Tumors

2026-2-1


The prostate is an important gland unique to men, located at the bottom of the bladder, and its main function is to secrete fluid that mixes with sperm to form semen. According to statistics, the volume of the prostate gland is generally only about 20 milliliters, which is a relatively small organ in the body. But it plays a crucial role in maintaining reproductive and urinary functions. However, many men may experience prostate enlargement in their fifties, and some may even progress to prostate cancer. Therefore, timely understanding of the prevention and treatment of prostate tumors is highly necessary for every male.

According to different pathological manifestations, prostate tumors can be divided into benign prostatic hyperplasia and malignant prostatic cancer. Among them, benign prostatic hyperplasia is more common, mainly appearing in elderly men, manifested as varying degrees of difficulty urinating, urgency urinating, frequency urinating, etc., seriously affecting daily life. The data shows that the probability of men over 60 years old suffering from prostate hyperplasia exceeds 50%, and it increases with age. About 80% of males aged 70 and above have varying degrees of prostate enlargement. Prostate cancer poses a greater threat as it can infiltrate and metastasize to surrounding tissues and organs, making it the second leading malignant tumor causing male death. Currently, there are approximately 1.8 million new cases of prostate cancer worldwide each year, with around 360000 deaths from the disease.

It is worth mentioning that the occurrence of prostate tumors is highly correlated with age. An epidemiological survey shows that the incidence rate of prostate cancer in men under 40 years old is extremely low, about one in 1000. The incidence rate began to increase significantly after the age of 50, and reached the peak around the age of 70. With the aging trend of the population, the incidence rate of prostate cancer in elderly men in China is also rising steadily. This is because as men age, their testosterone levels decrease, the metabolic activity of prostate cells decreases, and their ability to repair environmental carcinogens decreases, making them more susceptible to cancer.

So, how to detect the presence of prostate tumors as early as possible? The most widely used detection indicator currently is the level of prostate-specific antigen (PSA). PSA is an enzyme produced only by prostate cells and is normally present in very low levels in the blood. When prostate tumors occur, a large amount of PSA will seep into the bloodstream, causing a significant increase in its concentration. Therefore, detecting the concentration of PSA in serum can be an important biomarker for judging prostate lesions. PSA examination is simple and non-invasive, with clear results, and has become the most commonly used screening method for prostate tumors.

Of course, PSA testing also has certain limitations. Elevated PSA levels may be caused by prostatitis, trauma, and other factors, and there are also a small number of cases where cancer does not cause significant PSA abnormalities. In addition, there are also some patients, such as Mr. Li, whose PSA levels are low (2.5ng/ml), but have been confirmed by biopsy to have poorly differentiated prostate cancer. Therefore, PSA testing can only serve as a warning signal, and further diagnosis needs to be confirmed through imaging and pathological biopsy methods.

So what prevention and treatment measures should be taken after being diagnosed with prostate cancer? Below, we will discuss in detail the classification of prostate hyperplasia and prostate cancer based on typical cases.

The prevention and treatment of benign prostatic hyperplasia mainly include three aspects: lifestyle adjustment, medication treatment, and surgical intervention. Firstly, measures such as healthy diet, moderate exercise, smoking cessation and alcohol restriction can effectively reduce the risk of prostate hyperplasia. Sexual activity can also have a certain impact on the prostate. Excessive frequency may lead to fatigue and congestion of prostate tissue, increasing the risk of enlargement; Long term irregular sexual activity is also associated with increased risk of prostatitis and cancer.

Then, for patients who have already developed symptoms, medication or surgery can be chosen for treatment. Commonly used drugs include alpha blockers, 5-alpha-reductase inhibitors, etc. Mr. Zhang, aged 61, had a PSA level of 6ng/ml and exhibited significant symptoms such as urgency and frequency of urination. After oral treatment with dutasteride, his symptoms improved significantly. Surgical treatment achieves radical cure by removing or ablating enlarged prostate tissue. But the surgical trauma is significant, requiring general anesthesia and a long recovery period. For patients who cannot tolerate surgical trauma, drug therapy is the first choice; For patients who seriously affect their quality of life and have controllable surgical risks, mechanical resection is required to achieve complete treatment.

Compared to benign prostatic hyperplasia, prostate cancer is more harmful and difficult to treat. Prevention and treatment also require lifestyle adjustments, regular screening, and targeted active treatment. Firstly, ensuring a nutritious diet and moderate exercise can reduce the risk of prostate cancer. In addition, middle-aged and elderly men need to undergo PSA and other necessary tests every year to detect prostate cancer as early as possible.

Once diagnosed, the treatment of prostate cancer is complex and diverse, requiring a comprehensive assessment of the patient's specific condition. The main options include surgical resection of tumors, radiation therapy to kill cancer cells, endocrine and chemotherapy to inhibit cancer cell growth, or waiting for observation. For example, Mr. Wang, who is 70 years old, has a PSA level of 45ng/ml and his condition is progressing rapidly. He needs to undergo surgery to reduce residual cancer cells; Mr. Li, who is 75 years old and cannot tolerate surgery due to existing complications, chose targeted drug treatment to control his condition. The selection of treatment plan needs to be comprehensively evaluated based on factors such as age, tumor stage, and progression.

The prevention and treatment of prostate tumors are related to men's health and well-being. Only through scientific lifestyle adjustments, regular screening and monitoring, and targeted treatment interventions can the occurrence and development of this disease be effectively controlled. I hope this article can raise public awareness of prostate cancer prevention and treatment, and encourage more men to pay attention to their physical health and take active measures to protect themselves.